Universal Beteiligungs und Servicegesellschaft mbH Buys Shares of 15,259 AdaptHealth Corp. $AHCO

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in AdaptHealth Corp. (NASDAQ:AHCO) during the 2nd quarter, Holdings Channel reports. The institutional investor purchased 15,259 shares of the company’s stock, valued at approximately $144,000.

Other large investors have also made changes to their positions in the company. AlphaQuest LLC boosted its position in shares of AdaptHealth by 275.7% in the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock worth $37,000 after purchasing an additional 2,892 shares in the last quarter. Assetmark Inc. increased its position in AdaptHealth by 87.6% during the 2nd quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after buying an additional 2,581 shares in the last quarter. Brooklyn Investment Group raised its stake in AdaptHealth by 531.8% in the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock valued at $82,000 after buying an additional 6,366 shares during the last quarter. GAMMA Investing LLC boosted its holdings in AdaptHealth by 38.7% in the second quarter. GAMMA Investing LLC now owns 10,365 shares of the company’s stock worth $98,000 after acquiring an additional 2,892 shares in the last quarter. Finally, CWM LLC boosted its holdings in AdaptHealth by 1,562.1% in the second quarter. CWM LLC now owns 10,471 shares of the company’s stock worth $99,000 after acquiring an additional 9,841 shares in the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Canaccord Genuity Group upped their price objective on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of AdaptHealth in a research report on Wednesday. Zacks Research cut shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a report on Friday, September 19th. Finally, Wall Street Zen downgraded shares of AdaptHealth from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 8th. Five analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $13.60.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $9.65 on Friday. The company has a 50 day simple moving average of $9.26 and a two-hundred day simple moving average of $9.19. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of 17.55, a PEG ratio of 1.42 and a beta of 1.72. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 1.09. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.63.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The business had revenue of $820.31 million during the quarter, compared to analyst estimates of $799.62 million. During the same quarter in the previous year, the company earned $0.15 EPS. The firm’s revenue was up 1.8% compared to the same quarter last year. AdaptHealth has set its FY 2025 guidance at EPS. As a group, analysts predict that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.